RxDoctor Payments Data

Michael Sabia, MD

Pain Medicine · Voorhees, NJNPI 1780881029

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 58.3% of the total. Reporting peaked in 2019 at $8,635 and has fallen 79.8% since, to $1,748 in 2025. Among pain medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,369in general payments, 2019–2025

Across 73 payments — averaging $183.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$8K
  • Medtronic$1K
  • Boston Scientific$1K
  • Abbott$820
  • Nevro Corp.$626
  • Saluda Medical Americas, Inc.$479
  • plus $1K from 8 others

What the payments were for

  • Speaking & faculty fees$6,70050%
  • Travel & lodging$9157%
  • Food & beverage$5,75443%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,369 in reported general payments places this provider in the 90th percentile of 256 pain medicine providers in New Jersey.

See all pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$279,002
Medicare patients
707
Services billed
2,361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl57$34,373
Xtampza ErOxycodone Myristate19$13,110
Oxycodone Hcl381$8,426
Pregabalin203$7,905
Lidocaine29$7,645
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen267$5,936
Buprenorphine18$5,697
Tizanidine Hcl203$4,761
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen95$3,597
Gabapentin231$2,223
Naloxone Hcl22$1,300
Morphine Sulfate ErMorphine Sulfate43$1,202
Fentanyl14$959
Tramadol Hcl145$923
Celecoxib45$843

Paid to pharmacies, not to this prescriber.

Other pain medicine in Voorhees

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →